Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

EndoChoice nets $98.4mm via IPO

Executive Summary

EndoChoice Holdings Inc. (formerly EndoChoice Inc.; endoscopic devices) netted $98.4mm through its initial public offering of 7.05mm shares (including the overallotment) at $15 each, the low end of its $15-17 range.
Deal Industry
  • Medical Devices
  • Services
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
    • Infection Control-Sterilization
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register